PTH suppression by calcitriol does not predict off‐target actions in experimental CKD-Reference-Cited by-同舟云学术

PTH suppression by calcitriol does not predict off‐target actions in experimental CKD

Published:2020-06 Issue:3 Volume:8 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Svajger Bruno A.¹^ORCID,Pruss Cynthia M.¹^ORCID,Laverty Kimberly J.¹,Zelt Jason G. E.²³^ORCID,Jones Glenville¹,Kaufmann Martin¹,Petkovich Martin¹,Holden Rachel M.¹⁴,Adams Michael A.¹

Affiliation:

1. Department of Biomedical and Molecular Sciences Queen’s University Kingston ON Canada

2. Department of Cellular and Molecular Medicine Faculty of Medicine University of Ottawa Ottawa ON Canada

3. Molecular Function and Imaging Program The National Cardiac PET Centre, and the Advanced Heart Disease Program Division of Cardiology Department of Medicine University of Ottawa Heart Institute and University of Ottawa Ottawa Ontario Canada

4. Department of Medicine Queen’s University Kingston Ontario Canada

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.605

Reference49 articles.

1. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease

2. Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation

3. Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters

4. Vitamin D supplementation guidelines

5. Vitamin D supplementation guidelines for general population and groups at risk of Vitamin D deficiency in poland‐recommendations of the polish society of pediatric endocrinology and diabetes and the expert panel with participation of national specialist consultants and representatives of scientific societies‐2018 update;Rusinska A;Front Endocrinol (Lausanne),2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extended-Release Calcifediol: A Data Journey from Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism;Nephron;2024-04-24

2. Genomically anchored vitamin D receptor mediates an abundance of bioprotective actions elicited by its 1,25-dihydroxyvitamin D hormonal ligand;Vitamins and Hormones;2023

3. Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease;Journal of Nephrology;2021-06-25